ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

HEW Money Bills Mark Up Set May 26

May 20, 1977

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

November 28, 1986

In Belief: Warren Ross Named Director Of Louisville’s Brown Cancer Center; NCI Landow Offices Moved

August 5, 1988

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012